Stock 4507 SHIONOGI & CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Shionogi & Co., Ltd.

Equities

4507

JP3347200002

Market Closed - Japan Exchange
Other stock markets
 02:00:00 2024-07-09 am EDT 		5-day change 1st Jan Change
6,376 JPY +1.25% Intraday chart for Shionogi & Co., Ltd. +2.38% -6.21%
Jun. 25 Japanese Shares Close Higher as Officials Address Yen Volatility Concerns MT
Jun. 25 Shionogi & Co Introduces Covgoze Vaccine for Covid-19 in Japan MT

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Japanese Shares Close Higher as Officials Address Yen Volatility Concerns
Shionogi & Co Introduces Covgoze Vaccine for Covid-19 in Japan
Tokyo a stagné, Hong Kong déçue par le commerce extérieur chinois
Japan's Nikkei little changed ahead of key US data, central bank meetings
Japan's Nikkei edges down ahead of key US data, central bank meetings
Japan's Nikkei drifts sideways as more earnings, US CPI awaited
MÄRKTE ASIEN/Börsen wenig verändert - Mazda sehr schwach
MÄRKTE ASIEN/Uneinheitlich - Anleger meiden Risiken vor US-Preisdaten
Japan's Shionogi says COVID treatment did not meet endpoint in late-stage trial
Akili, Inc. Announces an Amendment to its Strategic Distribution Agreement with Shionogi & Co., Ltd
Shionogi & Co., Ltd. Revises Year-End Dividend Guidance for the Fiscal Year Ending March 31, 2024
Shionogi & Co., Ltd. Announces New Data from the European Real-World Evidence Study of Fetroja®/F etcroja® (cefiderocol)
Shionogi Completes Up to 75 Billion Yen Share Buyback
GSK Unit ViiV Healthcare's Injectable HIV Treatment Shows 'Superior Efficacy' in Late-stage Trial
Shionogi Buys Back Shares Worth Nearly 12 Billion Yen
GSK says ViiV's cabotegravir study supports longer HIV dose interval
GSK's ViiV Healthcare Says Four-month Interval Between Doses Possible for HIV Treatment Cabotegravir
Shionogi & Co., Ltd. Announces Xocova Obtains Standard Approval in Japan for the Treatment of SARS-CoV-2 Infection
US urges court to preserve Obamacare mandate to cover cancer screenings, HIV drugs
GSK's new HIV drug formula could support longer dosing intervals (March 4)
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 4507 Stock
  4. News Shionogi & Co., Ltd.
  5. Other languages